Skip to main content
SpringerLink
Log in

Textbook of Coronary Thrombosis and Thrombolysis

  • Book
  • © 1997

Overview

Editors:
  1. Richard C. Becker

    1. Cardiovascular Thrombosis Research Center, USA
      Coronary Care Unit, University of Massachusetts Medical School, Worcester

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Developments in Cardiovascular Medicine (DICM, volume 193)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 389.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 499.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 499.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (46 chapters)

  1. Clinical Application of Scientific Principles

    1. Thrombolytic Agents

      1. Staphylokinase: Biochemistry And Pharmacodynamics
        • Steven Vanderschueren, Désiré Collen
        Pages 257-262
      2. Novel Tissue Plasminogen Activators: Reteplase (<span class="u-small-caps">R</span>-PA)
        • Christoph Bode, Thomas K. Nordt, Benedikt Kohler, W. Douglas Weaver, Richard W. Smalling
        Pages 263-268
      3. Chemistry, Pharmacokinetics, and Pharmacodynamics of <span class="u-small-caps">T</span>-PA, TNK and DSPA Alpha 1
        • Steffen P. Christow, Dietrich C. Gulba
        Pages 269-282

    2. National Goals and Perspectives for Improving Patient Care: The National Heart Attack Alert Program

      1. National Goals and Perspectives for Improving Patient Care: the National Heart Attack Alert Program
        • Costas T. Lambrew
        Pages 285-286
      2. Delays in Treatment of Acute Myocardial Infarction in the Emergency Department: Reducing Door to Drug Time
        • Costas T. Lambrew
        Pages 287-292
      3. Factors Associated With Prehospital Delay And Overview Of Community Trials To Reduce The Duration Of Prehospital Delay In Patients With Symptoms Of Acute Coronary Disease
        • Robert J. Goldberg, Voula Osganian
        Pages 293-300
      4. Emergency Medical Services
        • James M. Atkins
        Pages 301-311
      5. Prehospital Approaches to Treating Sudden Cardiac Death and Acute Myocardial Infarction
        • Joseph P. Ornato, Mary Ann Peberdy
        Pages 313-319
      6. Identification of Acute Cardiac Ischemia in the Emergency Department
        • Harry P. Selker, Robert J. Zalenski
        Pages 321-331

    3. Prehospital Strategies for the Treatement of Acute Myocardial Infarction

      1. The Scientific Basis and Rationale For Early Thrombolytic Therapy
        • Arie Roth
        Pages 335-344
      2. Patient Selection for Thrombolytic Therapy for Evolving Myocardial Infarction
        • Alfred E. R. Arnold, Eric Boersma, Maureen van der Vlugt, Maarten L. Simoons
        Pages 345-354

    5. Plasma Markers of Infarction, Thrombosis, and Thrombolysis

      1. Early Diagnosis of Myocardial Infarction with MB-CK Subforms
        • Robert Roberts
        Pages 401-412
      2. Troponins as early markers of acute myocardial infarction
        • Sanjay Dixit, Allan S. Jaffe
        Pages 413-420
      3. Markers of Thrombosis and Fibrinolysis
        • L. Veronica Lee, Dana R. Abendschein, Paul R. Eisenberg
        Pages 421-447
      4. Markers of Coronary Recanalization after Thrombolysis
        • Dana R. Abendschein
        Pages 449-461

    6. Anticoagulation Monitoring

      1. Anticoagulant Monitoring
        • James M. Wilson
        Pages 465-482
      2. Anticoagulation Monitoring for Percutaneous Transluminal Coronary Angioplasty
        • James J. Ferguson, James M. Wilson
        Pages 483-494
Back to top

Keywords

About this book

Teleologically, the hemostatic mechanism is among The of Coronary Thrombosis and the most fundamental yet complex physiologic pro- in essence, represents a heartfelt gift of cesses in humans. Early scientists and physicians were knowledge from a dedicated group of scientists and fascinated by the blood's ability to remain in a liquid clinicians, who collectively have set out on a mission state only to clot in response to vascular injury. The to minimize the societal impact of"hemostasis in the cellular and noncellular components of normal wrong place. " The book is divided into four distinct hemostasis took centuries to discover, and the intrica- sections: Part 1, Scientific Principles, lays down the cies of their delicate interactions are still being unrav- supporting foundation; Part 2, Clinical Application eled today. As is so often the case, an in-depth of Scientific Principles, places the knowledge base in appreciation of physiologic hemostasis, representing a a working perspective, directly applying science to basic life-sustaining sequence of events, paved the patient care; Part 3, New Dimensions, provides a way for understanding abnormal hemostasis or glimpse of tomorrow. Steering the field clear of se- pathologic thrombosis. Aristotle, Malpighi, and proclaimed victory and the dangers of complacency as Osier, representing but a few of the founding fathers we move into the 21st century, Part 4, Evolution of in the field, would undoubtedly be honored to see Thrombocardiology, focuses on laboratory standards, their observations form the template for lifesaving clinical trials, and drugs in development.

Editors and Affiliations

  • Cardiovascular Thrombosis Research Center, USA

    Richard C. Becker

  • Coronary Care Unit, University of Massachusetts Medical School, Worcester

    Richard C. Becker

Bibliographic Information

Publish with us

Policies and ethics

Back to top

Search

Navigation